Zdrowie i gospodarka · 13/04/2023
FDA Releases Revised Draft Guidance for Evaluating Skin Irritation and Sensitization of Transdermal and Topical Delivery Systems
The FDA has released a revised draft guidance for industry to evaluate the skin irritation and sensitization potential of transdermal and topical delivery systems for abbreviated new drug applications (ANDAs).
Source: Federal Register — Food and Drug AdministrationOpen original release →